These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31733424)

  • 21. [Anti-myelin oligodendrocyte glycoprotein antibody associated encephalitis].
    Fujimori J
    Rinsho Shinkeigaku; 2020 Feb; 60(2):117-119. PubMed ID: 31956198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
    Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A
    J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An 11 year old woman with myelin-oligodendrocyte glycoprotein antibody showing various phenotypes of central nervous system disorders in one year].
    Oshibe N; Takeshita Y; Takahashi S; Oishi M; Sano Y; Kanda T
    Rinsho Shinkeigaku; 2022 Mar; 62(3):211-216. PubMed ID: 35228464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
    Bruijstens AL; Lechner C; Flet-Berliac L; Deiva K; Neuteboom RF; Hemingway C; Wassmer E; ; Baumann M; Bartels F; Finke C; Adamsbaum C; Hacohen Y; Rostasy K
    Eur J Paediatr Neurol; 2020 Nov; 29():2-13. PubMed ID: 33162302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MOG antibody-related disorders: common features and uncommon presentations.
    Cobo-Calvo Á; Ruiz A; D'Indy H; Poulat AL; Carneiro M; Philippe N; Durand-Dubief F; Deiva K; Vukusic S; Desportes V; Marignier R
    J Neurol; 2017 Sep; 264(9):1945-1955. PubMed ID: 28770374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Disseminated Encephalomyelitis (ADEM) and Increased Intracranial Pressure Associated With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies.
    Narayan RN; Wang C; Greenberg BM
    Pediatr Neurol; 2019 Oct; 99():64-68. PubMed ID: 31248672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis.
    Tsuburaya RS; Miki N; Tanaka K; Kageyama T; Irahara K; Mukaida S; Shiraishi K; Tanaka M
    Brain Dev; 2015 Jan; 37(1):145-8. PubMed ID: 24582475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody.
    Santoro JD; Chitnis T
    Neuropediatrics; 2019 Oct; 50(5):273-279. PubMed ID: 31340401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder.
    Narayan R; Simpson A; Fritsche K; Salama S; Pardo S; Mealy M; Paul F; Levy M
    Mult Scler Relat Disord; 2018 Oct; 25():66-72. PubMed ID: 30048919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset acute disseminated encephalomyelitis followed by optic neuritis without anti-myelin oligodendrocyte glycoprotein antibodies: a biopsied case report.
    Mori M; Sakai K; Tada Y; Nozaki I; Usui Y; Ichinose T; Tanaka S; Takahashi T; Nakada M; Yamada M
    Neurol Sci; 2021 Nov; 42(11):4731-4735. PubMed ID: 34170431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
    Thulasirajah S; Pohl D; Davila-Acosta J; Venkateswaran S
    Neuropediatrics; 2016 Aug; 47(4):245-52. PubMed ID: 27128728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.
    Hacohen Y; Rossor T; Mankad K; Chong W'; Lux A; Wassmer E; Lim M; Barkhof F; Ciccarelli O; Hemingway C
    Dev Med Child Neurol; 2018 Apr; 60(4):417-423. PubMed ID: 29288492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of bilateral limbic and recurrent unilateral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody positivity.
    Horita T; Inoue T; Kuki I; Nagase S; Yamamoto N; Yamada N; Oki K; Nukui M; Okazaki S; Amo K; Kawawaki H; Sakuma H; Togawa M
    Brain Dev; 2022 Mar; 44(3):254-258. PubMed ID: 34802814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion.
    Miyaue N; Yamanishi Y; Tada S; Ando R; Yabe H; Nagai M; Nomoto M
    Mult Scler Relat Disord; 2019 Jun; 31():62-64. PubMed ID: 30933712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
    Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
    J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MOG-Ab titer-guided approach for steroid tapering to prevent relapse in children with mog antibody-associated adem diseases: A case report.
    Kurane K; Monden Y; Tanaka D; Gunji Y; Ikeda T; Miyauchi A; Osaka H; Takahashi T; Yamagata T
    Mult Scler Relat Disord; 2020 Oct; 45():102320. PubMed ID: 32622298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease].
    Fujimori J; Nakashima I
    Brain Nerve; 2021 May; 73(5):483-488. PubMed ID: 34006679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.